You just read:

Nuvilex, Inc. Analyst Report: Potentially Revolutionary Technology Positions Biopharmaceutical Firm as a Cancer Market Competitor - Fundamentals Need to Catch up With Expectations by Brokerbank Securities, Inc.

News provided by

BrokerBank Securities, Inc.

Apr 15, 2014, 07:00 ET